Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Cook

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|May 2, 2012
Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatmentJ Mirjam Oudijk, Helen McIlleron, Veronica Mulenga, et al.
Plos One|July 10, 2020
Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapyRuth E Farmer, Rhian Daniel, Deborah Ford, et al.
BMJ Open|November 21, 2023
Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysisJoanna Dodkins, Adrian Cook, Melanie Morris, et al.
AIDS (London, England)|January 7, 2017
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tabletsAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African ChildrenAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
BMJ Oncology|April 3, 2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluationJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
BMJ Open|February 28, 2024
What can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in EnglandMelanie Morris, Adrian Cook, Joanna Dodkins, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|May 2, 2012
Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatmentJ Mirjam Oudijk, Helen McIlleron, Veronica Mulenga, et al.
Plos One|July 10, 2020
Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapyRuth E Farmer, Rhian Daniel, Deborah Ford, et al.
BMJ Open|November 21, 2023
Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysisJoanna Dodkins, Adrian Cook, Melanie Morris, et al.
AIDS (London, England)|January 7, 2017
Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tabletsAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
AIDS (London, England)|April 19, 2013
Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?Quirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African ChildrenAndrzej Bienczak, Paolo Denti, Adrian Cook, et al.
BMJ Oncology|April 3, 2025
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluationJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
BMJ Open|February 28, 2024
What can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in EnglandMelanie Morris, Adrian Cook, Joanna Dodkins, et al.
Pageof 6